By Admin 
Us tarifs on pharmaceuticals: US President Donald Trump is taking one step after the other, which are constantly becoming troublesome for Americans. On the one hand, while the US court termed Tariff as illegal, on the other hand Trump is not ready to withdraw from his move. Now pharmaceutical companies have come in their target.
According to news agency AP, the Trump administration has decided to put heavy tariffs on imported medicines. These rates will be up to 200 percent on some medicines. President Trump’s effort is to increase the scope of tariff to reach the pharmaceutical sector after auto and steel. This will directly affect those medicines, which were not yet imposed customs. That is, this decision of Trump can affect the general American public.
Why American people in worry?
Experts believe that the supply chain will be affected on one side due to heavy tariffs on medicines, then the risk of lack of medicines will increase on the other side. The Trump administration is using section 232 of the Trade Examination Act 1962 to justify its move. It is being argued that to avoid lack of drugs, it is necessary to increase production at the domestic level, so that the situation like Kovid-19 is not again.
Recently, in the US-Europe trading decision, up to 15 percent tariffs were imposed on some European goods, including medicines. Despite this, the Trump administration is preparing to put more tariffs.
What will be the immediate effect?
It has been suggested by the White House that about one and a half years should be given to apply higher tariffs. Many companies have already increased imports and have increased the prices of medicines.
Jeffer’s analyst David Windle warned that this decision could not be implemented before 2026 or before 2027. The short -term effect will be that the lack of drugs will increase. Whereas in a long time it will directly affect the cost and supply.
Also read: SEBI’s new rule on trading in the stock market will be applicable from October 1, know what will be the effect on investors?